Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers
Completed · Phase 1
Conditions studied: Healthy, Multiple Sclerosis
In brief
The purpose of this study is to characterize the pharmacokinetic (PK) profile, safety, and tolerability of peginterferon beta-1a (BIIB017) delivered by the single-use autoinjector or prefilled syringe (PFS) in healthy volunteers to support the development of the autoinjector.
Key facts
- Study ID
- NCT01610310
- Run by
- Biogen
- People needed
- 55
- Starts
- 2012-06-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2014-06-13
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Saint Paul, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.